Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Baudax Bio, Inc.
| Metric | Baudax Bio, Inc. Healthcare |
|---|---|
| Quality Score | 52 / 100 |
| Revenue (latest) | $1M |
| Net income (latest) | −$59M |
| Operating margin | −4477.0% |
| Net margin | −4633.2% |
| Return on equity | 242.5% |
| Return on assets | −586.1% |
| Return on capital (ROCE) | — |
| Debt / equity | — |
| Revenue growth (YoY) | 17.5% |
| Altman Z″ (distress) | -110.72 |
| Accruals / assets | −309.0% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.